GSTM1 and colorectal carcinoma: Consequently, we posit that the integration of an f-Hb-guided framework for interscreening intervals has the potential to not only curtail the incidence of advanced CRC cases and concomitant mortalities, but also to alleviate the burden associated with colonoscopy, by rationalizing the volume of FIT tests and colonoscopies.